
Cell and gene therapy platform targeting aging and cancer
pitch_v1_importSee something off about this company?
As cells age, their telomeres naturally shorten, eventually reaching a point where cells can no longer divide. This cellular aging is artificially accelerated during ex-vivo manufacturing of cell and gene therapies. Telos's mission is to overcome these limitations by safely lengthening telomeres, thus boosting the efficacy of cell therapies. Telovance™ is a protein complex that is delivered inside the cells during the process of cell therapy manufacturing to prevent the rapid shortening of cellular telomeres. This will help create a more robust and effective cell therapy product. Telovance™ is designed to seamlessly integrate into current and next gen cell manufacturing processes